U.S. Semiconductors Stock News

If you have been keeping an eye on THOR Industries after its most recent close at $106.41, you are not alone. Investors are asking themselves whether now is the time to get in, hang on, or cash out. Over the past year, the stock has logged a modest 1.6% gain, while its three-year rise of nearly 50% suggests some significant long-term growth. At the same time, the past month has seen the shares slide 5.3%, giving some people pause after a strong start to the year with a 12.6% return...

So, you have got your eye on Impinj stock and are wondering if this is the moment to make your move or to hold back. You are not alone. Impinj has been catching the attention of investors lately, swinging upward by 8.8% in just the past week and logging a solid 33.6% return so far this year. Looking even further back, the story gets more dramatic: a 140.2% gain over three years and a staggering 537.6% over five years. Yet, a glance at the past twelve months reveals a -10.1% drop, a reminder...

Making decisions about Flagstar Financial stock can feel like reading tea leaves, but let's cut through the noise together. If you have been tracking the share price lately, you will know it's been an eventful ride. Over the past week, the stock bounced 5.1% higher, but that move comes after a tough 30 days, where it lost 6.7%. Year to date, though, Flagstar Financial is up an impressive 31.0%, even with a choppy performance over longer periods such as the last three and five years. Behind...

In the past 60 days, Montrose Environmental Group’s consensus estimate for current year earnings has doubled and the company now holds a top analyst rating from Zacks (Rank #1). This marked upward revision reflects growing analyst optimism and highlights a significant shift in expectations for Montrose’s near-term financial performance. We’ll explore how the substantial increase in earnings estimates could influence Montrose Environmental Group’s overall investment narrative and...

Thinking about what to do with Rush Street Interactive stock? You are not alone as investors everywhere are sizing up this high-flyer after its wild ride over the past few years. After all, shares have soared 423.5% over the last three years and delivered an impressive 79.0% jump in just the past twelve months. Even with a steep slip of 16.6% in the most recent week and an 11.8% dip over the last month, the stock remains up 36.0% year-to-date. This hints at strong underlying momentum and...

RBC Capital has reiterated its positive outlook for Brookfield Renewable, highlighting enhanced growth visibility and strong confidence in the company's long-term expansion plans following recent operational results. Despite reporting lower-than-expected Q2 2025 profits, Brookfield Renewable saw a 10% year-over-year rise in Funds From Operations, driven largely by its hydropower and distributed energy businesses. We'll examine how analyst confidence in Brookfield Renewable's operational...

If you are deciding what to do with Soleno Therapeutics stock, you are in some good company. With so much of Wall Street focused on biotech movers, it is easy to understand why Soleno has caught investors' attention. The share price tells a story filled with wild swings, growing optimism, and big questions about what comes next. Just in the last week, Soleno’s stock dipped by 13.5%. That sharp move caught some traders by surprise, especially after a long run higher this year. Despite a tough...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...

If you have been watching Grand Canyon Education lately, you have probably noticed the stock has delivered both surprises and impressive staying power. After a slight dip of -0.9% over the last week, you might be wondering if this is just noise or the start of something more meaningful. Looking back a little further, the story gets much more compelling: a 5.7% gain over the past 30 days, 33.5% up year to date, and a dramatic 58.2% leap in the last year alone. Even more striking is that Grand...

If you’re debating what to do with shares of Arcellx, you’re definitely not alone. It’s the kind of stock that makes investors pause and reconsider, especially after such a striking run. Let’s look at the numbers: Arcellx’s price gained 16.2% over the last month, climbed 6.7% in just seven days, and has rocketed an eye-watering 346.5% over three years. It’s not every day you see those kinds of returns, and the buzz in biotech circles hasn’t hurt either, as recent market developments have...

Are you wondering if Super Group (SGHC) stock deserves a spot in your portfolio, or if its best days are already behind it? You are not alone. Lately, there has been a lot of buzz around this company, and anyone watching its price chart would be hard pressed to ignore the explosive moves: up an eye-popping 119.5% year-to-date and a jaw-dropping 269.7% over the last twelve months. Even more impressive, the return over three years has reached 272.9%. Just in the last week and month, Super...

If you’re holding shares of RBC Bearings, or thinking about jumping in, chances are you’re watching those price swings and wondering: is there more gas in the tank, or is it time to tap the brakes? Even with a minor dip of -2.6% in the past week and -3.4% over the past month, the stock is still up an impressive 25.7% year-to-date. Zoom out to a wider lens, and that momentum looks even stronger with returns of 30.6% over a year, 72.8% over three years, and a whopping 193.1% over five years,...

Wondering whether to hold on to ZoomInfo Technologies, make a move, or simply stay on the sidelines? You are not alone. This stock has been catching the eye of investors trying to decide if its latest moves are signs of a fresh start or a warning sign. After a fairly positive climb of 4.3% over the last 30 days, ZoomInfo’s stock took a modest dip this week, closing at $10.67, down 8.1% in the past seven days. For the year, it is up just 2.0%, though the path here has been anything but smooth...

Eagle Materials' (NYSE:EXP) stock up by 9.7% over the past three months. Given that the market rewards strong...

If you are considering what to do with Essex Property Trust stock right now, you are not alone. Many investors are weighing whether the recent dip is a sign of opportunity or cause for caution. After a three-year return of 32.5% and a five-year gain of 43.5%, Essex has clearly delivered for long-term investors. Lately, though, the story has been a little bumpier. The stock closed recently at $261.34, down 1.8% in the last week, 2.5% for the past month, and 6.5% year to date. Even over the...

If you're holding Atkore shares or thinking about jumping in, you're probably asking the big question right now: are these prices offering a good deal, or has the market priced in all the potential? The answer isn't straightforward, but a closer look at Atkore's recent moves makes things interesting. Over the past week, Atkore has climbed 4.9%, adding to a 7.5% gain this past month. These short-term bumps might signal renewed optimism or changing risk perceptions among investors. Step back,...

Deciding what to do with your Tetra Tech shares right now might feel like a tough call, but you are definitely not alone. The stock has given investors a bit of a roller-coaster ride lately, with a slight 0.7% gain over the last week. It is still down 6.2% for the month and off 15.1% year-to-date. The longer view tells a different story, however. Over three years, Tetra Tech is up 36.0% and has delivered a strong 61.6% return over the past five years. That contrast between short-term pressure...

On October 6, 2025, Senseonics Holdings announced preliminary unaudited revenue for the third quarter ended September 30, reporting approximately US$8.1 million, an increase of 91% over the same period in 2024, primarily attributed to roughly 160% new patient growth in the U.S. This upturn in both revenue and new patient adoption highlights more robust market traction, suggesting a potential acceleration in demand for the company’s continuous glucose monitoring systems. We’ll now explore how...

If you're standing at the crossroads of what to do with your Knife River shares or thinking of putting some capital to work, you're not alone. Knife River’s recent performance has grabbed the attention of both cautious investors and opportunists, sparking plenty of debate on whether the current price fairly reflects the company’s long-term prospects. Knife River's stock price has seen a difficult stretch lately. Down 3.9% in the last week, 11.6% in the last month, and a hefty 29.2%...

AC Immune (NasdaqGM:ACIU) just shared peer-reviewed data from its Phase 1b/2a trial of ACI-35.030, an active immunotherapy targeting Tau in early Alzheimer's, developed with Janssen. The findings highlight a rapid and sustained antibody response as well as a clean safety profile. See our latest analysis for AC Immune. With this encouraging clinical update, AC Immune is starting to turn heads, especially as the company’s latest innovation underscores its growing potential in Alzheimer’s...

In September 2025, Bayer’s Consumer Health division announced it had selected Interpublic Group as its exclusive global creative, production, and media agency partner for iconic self-care brands including Aspirin and Claritin. This partnership signals Bayer’s commitment to integrated marketing powered by GenAI for both global consistency and tailored local consumer engagement. We'll review how IPG’s appointment as Bayer’s lead global partner could strengthen its client portfolio and...

Cheche Group Inc.'s ( NASDAQ:CCG ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing investment...

Key Insights Institutions' substantial holdings in DorianG implies that they have significant influence over the...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...